| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.98 | 0 | 0.985 | Leukotriene antagonist | 0.931 0.001 CHEMBL3526238 0.983 0 CHEMBL3526481 0.985 0 CHEMBL3526239 0.984 0 CHEMBL3526241 0.948 0.001 CHEMBL3526240 | CHEMBL3526239 | |
| 0.948 | 0.001 | 0.948 | Leukotriene D4 antagonist | 0.859 0.001 CHEMBL3526238 0.913 0.001 CHEMBL3526481 0.907 0.001 CHEMBL3526239 0.946 0.001 CHEMBL3526241 0.918 0.001 CHEMBL3526240 | ||
| 0.924 | 0 | 0.937 | Leukotriene C antagonist | 0.577 0.001 CHEMBL3526238 0.849 0 CHEMBL3526481 0.937 0 CHEMBL3526239 0.753 0 CHEMBL3526241 0.844 0 CHEMBL3526240 | CHEMBL3526239 | |
| 0.923 | 0 | 0.931 | Leukotriene C4 antagonist | 0.57 0.001 CHEMBL3526238 0.85 0 CHEMBL3526481 0.931 0 CHEMBL3526239 0.752 0 CHEMBL3526241 0.844 0 CHEMBL3526240 | CHEMBL3526239 | |
| 0.856 | 0.005 | 0.856 | Toll-Like receptor 7 agonist | 0.682 0.01 CHEMBL3526238 0.836 0.005 CHEMBL3526481 0.831 0.005 CHEMBL3526239 0.781 0.005 CHEMBL3526241 0.8 0.005 CHEMBL3526240 | ||
| 0.853 | 0.005 | 0.853 | Toll-Like receptor agonist | 0.676 0.01 CHEMBL3526238 0.833 0.005 CHEMBL3526481 0.827 0.005 CHEMBL3526239 0.775 0.005 CHEMBL3526241 0.795 0.005 CHEMBL3526240 | ||
| 0.785 | 0.017 | 0.909 | Antiinflammatory | 0.619 0.049 CHEMBL3526238 0.837 0.011 CHEMBL3526481 0.77 0.019 CHEMBL3526239 0.909 0.005 CHEMBL3526241 0.739 0.024 CHEMBL3526240 | CHEMBL3526241 | |
| 0.639 | 0.002 | 0.639 | Leukotriene synthesis inhibitor | 0.464 0.003 CHEMBL3526238 0.566 0.002 CHEMBL3526481 0.604 0.002 CHEMBL3526239 0.505 0.003 CHEMBL3526241 0.597 0.002 CHEMBL3526240 | ||
| 0.375 | 0.054 | 0.384 | Streptokinase A inhibitor | 0.175 0.151 CHEMBL3526238 0.294 0.082 CHEMBL3526481 0.384 0.051 CHEMBL3526239 0.257 0.099 CHEMBL3526241 0.317 0.072 CHEMBL3526240 | CHEMBL3526239 | |
| 0.245 | 0.024 | 0.263 | Phospholipase A2 inhibitor | 0.147 0.078 CHEMBL3526238 0.235 0.027 CHEMBL3526481 0.263 0.02 CHEMBL3526239 0.18 0.054 CHEMBL3526241 0.219 0.034 CHEMBL3526240 | CHEMBL3526239 | |
| 0.284 | 0.079 | 0.409 | Lipoxygenase inhibitor | 0.215 0.126 CHEMBL3526238 0.264 0.091 CHEMBL3526481 0.409 0.035 CHEMBL3526239 0.213 0.127 CHEMBL3526241 0.316 0.064 CHEMBL3526240 | CHEMBL3526239 | |
| 0.216 | 0.06 | 0.216 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.184 0.09 CHEMBL3526481 0.206 0.068 CHEMBL3526239 0.172 0.103 CHEMBL3526241 0.185 0.088 CHEMBL3526240 | ||
| 0.296 | 0.167 | 0.505 | Cyclophilin D inhibitor | 0.505 0.049 CHEMBL3526481 0.301 0.162 CHEMBL3526239 0.263 0.198 CHEMBL3526241 0.489 0.054 CHEMBL3526240 | CHEMBL3526481 | |
| 0.118 | 0.005 | 0.118 | Thromboxane synthase inhibitor | 0.072 0.016 CHEMBL3526238 0.088 0.009 CHEMBL3526481 0.094 0.007 CHEMBL3526239 0.073 0.015 CHEMBL3526241 0.09 0.008 CHEMBL3526240 | ||
| 0.112 | 0.014 | 0.112 | Elastase 1 inhibitor | 0.112 0.014 CHEMBL3526238 0.104 0.018 CHEMBL3526481 0.108 0.016 CHEMBL3526239 0.098 0.021 CHEMBL3526241 0.108 0.016 CHEMBL3526240 | ||
| 0.095 | 0.008 | 0.095 | Heme oxygenase stimulant | 0.094 0.009 CHEMBL3526238 0.09 0.01 CHEMBL3526481 0.094 0.009 CHEMBL3526239 0.091 0.01 CHEMBL3526241 0.094 0.009 CHEMBL3526240 | ||
| 0.145 | 0.059 | 0.164 | Farnesoid X receptor antagonist | 0.142 0.063 CHEMBL3526481 0.164 0.039 CHEMBL3526239 0.143 0.061 CHEMBL3526241 0.139 0.067 CHEMBL3526240 | CHEMBL3526239 | |
| 0.167 | 0.092 | 0.18 | Hepatoprotectant | 0.16 0.1 CHEMBL3526481 0.18 0.08 CHEMBL3526239 0.159 0.1 CHEMBL3526241 0.159 0.1 CHEMBL3526240 | CHEMBL3526239 | |
| 0.123 | 0.051 | 0.123 | Nav1.5 sodium channel blocker | 0.11 0.068 CHEMBL3526239 | ||
| 0.086 | 0.017 | 0.091 | Thromboxane antagonist | 0.091 0.014 CHEMBL3526238 0.057 0.035 CHEMBL3526481 0.071 0.025 CHEMBL3526239 0.049 0.043 CHEMBL3526241 0.06 0.032 CHEMBL3526240 | CHEMBL3526238 | |
| 0.073 | 0.005 | 0.074 | p53 inhibitor | 0.074 0.005 CHEMBL3526238 0.07 0.005 CHEMBL3526481 0.067 0.006 CHEMBL3526239 0.07 0.005 CHEMBL3526241 0.071 0.005 CHEMBL3526240 | CHEMBL3526238 | |
| 0.102 | 0.047 | 0.115 | ABCA1 expression enhancer | 0.108 0.04 CHEMBL3526238 0.086 0.073 CHEMBL3526481 0.1 0.05 CHEMBL3526239 0.115 0.034 CHEMBL3526241 0.085 0.075 CHEMBL3526240 | CHEMBL3526241 | |
| 0.103 | 0.061 | 0.133 | 5-Lipoxygenase inhibitor | 0.094 0.068 CHEMBL3526238 0.133 0.044 CHEMBL3526239 0.084 0.077 CHEMBL3526241 0.084 0.077 CHEMBL3526240 | CHEMBL3526239 | |
| 0.102 | 0.061 | 0.16 | Bronchodilator | 0.115 0.048 CHEMBL3526239 0.16 0.028 CHEMBL3526241 | CHEMBL3526241 | |
| 0.158 | 0.128 | 0.208 | Hypolipemic | 0.161 0.126 CHEMBL3526238 0.159 0.128 CHEMBL3526239 0.208 0.088 CHEMBL3526241 | CHEMBL3526241 | |
| 0.094 | 0.065 | 0.103 | Lanosterol 14 alpha demethylase inhibitor | 0.103 0.052 CHEMBL3526241 | CHEMBL3526241 | |
| 0.088 | 0.065 | 0.097 | Thioredoxin inhibitor | 0.085 0.071 CHEMBL3526238 0.097 0.052 CHEMBL3526239 0.084 0.074 CHEMBL3526240 | CHEMBL3526239 | |
| 0.055 | 0.035 | 0.065 | Leukotriene B4 antagonist | 0.059 0.029 CHEMBL3526238 0.053 0.038 CHEMBL3526481 0.063 0.025 CHEMBL3526239 0.065 0.023 CHEMBL3526241 0.05 0.044 CHEMBL3526240 | CHEMBL3526241 | |
| 0.035 | 0.017 | 0.035 | AMPA 2 receptor antagonist | 0.032 0.019 CHEMBL3526238 0.027 0.024 CHEMBL3526481 0.029 0.022 CHEMBL3526239 0.032 0.019 CHEMBL3526240 | ||
| 0.063 | 0.047 | 0.077 | Beta 3 adrenoreceptor antagonist | 0.077 0.025 CHEMBL3526239 | CHEMBL3526239 | |
| 0.031 | 0.017 | 0.033 | Liver X receptor alpha antagonist | 0.031 0.017 CHEMBL3526238 0.033 0.014 CHEMBL3526239 0.028 0.023 CHEMBL3526241 | CHEMBL3526239 | |
| 0.065 | 0.053 | 0.082 | Peroxisome proliferator-activated receptor gamma agonist | 0.064 0.055 CHEMBL3526238 0.065 0.053 CHEMBL3526239 0.082 0.039 CHEMBL3526240 | CHEMBL3526240 | |
| 0.032 | 0.02 | 0.034 | Liver X receptor antagonist | 0.032 0.02 CHEMBL3526238 0.034 0.019 CHEMBL3526239 | CHEMBL3526239 | |
| 0.041 | 0.033 | 0.041 | Liver X receptor agonist | 0.041 0.034 CHEMBL3526238 0.041 0.034 CHEMBL3526239 | ||
| 0.052 | 0.049 | 0.066 | Prostaglandin EP2 antagonist | 0.056 0.045 CHEMBL3526238 0.066 0.036 CHEMBL3526241 | CHEMBL3526241 | |
| 0.043 | 0.047 | 0.047 | Prostaglandin antagonist | 0.047 0.042 CHEMBL3526238 | CHEMBL3526238 | |
| 0.157 | 0.167 | 0.187 | Hypoglycemic | 0.187 0.126 CHEMBL3526239 0.182 0.131 CHEMBL3526240 | CHEMBL3526239 | |
| 0.049 | 0.064 | 0.067 | HIV-1 integrase (3'-Processing) inhibitor | 0.067 0.041 CHEMBL3526239 | CHEMBL3526239 | |
| 0.069 | 0.084 | 0.163 | Antineoplastic alkaloid | 0.163 0.024 CHEMBL3526240 | CHEMBL3526240 | |
| 0.029 | 0.062 | 0.055 | Thromboxane A2 antagonist | 0.055 0.032 CHEMBL3526238 | CHEMBL3526238 | |
| 0.037 | 0.073 | 0.051 | HIV-1 integrase (Strand Transfer) inhibitor | 0.051 0.049 CHEMBL3526239 | CHEMBL3526239 | |
| 0.108 | 0.16 | 0.16 | Nitric oxide antagonist | 0.16 0.087 CHEMBL3526481 0.132 0.116 CHEMBL3526239 | CHEMBL3526481 | |
| 0.119 | 0.188 | 0.156 | Platelet antagonist | 0.156 0.138 CHEMBL3526238 | CHEMBL3526238 | |
| 0.113 | 0.202 | 0.64 | Free radical scavenger | 0.64 0.007 CHEMBL3526238 0.193 0.104 CHEMBL3526239 | CHEMBL3526238 | |
| 0.103 | 0.247 | 0.505 | Antioxidant | 0.505 0.019 CHEMBL3526238 0.176 0.136 CHEMBL3526239 | CHEMBL3526238 | |
| 0.053 | 0.217 | 0.244 | Bone formation stimulant | 0.244 0.026 CHEMBL3526240 | CHEMBL3526240 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |